{"id":815540,"date":"2025-02-20T08:09:47","date_gmt":"2025-02-20T13:09:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/"},"modified":"2025-02-20T08:09:47","modified_gmt":"2025-02-20T13:09:47","slug":"novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/","title":{"rendered":"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">GAITHERSBURG, Md.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Feb. 20, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M\u2122 adjuvant, today announced it will report its fourth quarter and full year 2024 financial results and operational highlights at <span class=\"xn-chron\">8:30 a.m. Eastern Time<\/span> (ET) on <span class=\"xn-chron\">Thursday, February 27, 2025<\/span>. Details of the event and replay are as follows:<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Conference call details:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen3\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Date:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">February 27, 2025<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Time:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">8:30 a.m. U.S. ET<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">URL to register phone:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <u><br \/>\n                    <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4366527-1&amp;h=2818717660&amp;u=https%3A%2F%2Femportal.ink%2F3PsP11e&amp;a=https%3A%2F%2Femportal.ink%2F3PsP11e\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">https:\/\/emportal.ink\/3PsP11e<\/a><br \/>\n                  <\/u><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Dial-in number:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(800) 836-8184 (Domestic) or<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen3\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(+1) (646) 357-8785 (International)<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Webcast:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">\u00a0 <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4366527-1&amp;h=4113808681&amp;u=https%3A%2F%2Fir.novavax.com%2Fevents%23future%3A2023%3A2&amp;a=ir.novavax.com%2Fevents\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">ir.novavax.com\/events<\/a><\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<ul type=\"disc\">\n<li>\n          <i>Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.<\/i>\n        <\/li>\n<li>\n          <i>Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.<\/i>\n        <\/li>\n<li>\n          <i>To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.<\/i>\n        <\/li>\n<\/ul>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Replay details:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Date:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Available starting at 11:30 a.m. U.S. ET, February 27, 2025, until 11:59 p.m. U.S. ET, March 6, 2025<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Dial-in number:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(888) 660-6345 (Domestic) or<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen5\" colspan=\"1\" rowspan=\"1\">\n              \n            <\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">(+1) (646) 517-4150 (International)<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Passcode:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">79349#<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Webcast:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen4\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4366527-1&amp;h=3396958448&amp;u=https%3A%2F%2Fir.novavax.com%2Fevents&amp;a=ir.novavax.com%2Fevents\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">ir.novavax.com\/events<\/a>, until March 29, 2025<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\n        <b>About Novavax<br \/><\/b>Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in <span class=\"xn-location\">Gaithersburg, Md.<\/span>, U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax&#8217;s patented Matrix-M adjuvant to enhance the immune response. The Company&#8217;s portfolio includes its COVID-19 vaccine and its pipeline includes COVID-19-Influenza Combination\u00a0and stand-alone influenza vaccine candidates. In addition, Novavax&#8217;s adjuvant is included in the <span class=\"xn-org\">University of Oxford<\/span> and Serum Institute of <span class=\"xn-location\">India&#8217;s<\/span> R21\/Matrix-M malaria vaccine. Please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4366527-1&amp;h=2848379934&amp;u=https%3A%2F%2Fwww.novavax.com%2Fhome%2Fusa&amp;a=novavax.com\" target=\"_blank\" rel=\"nofollow\">novavax.com<\/a>\u00a0and <u><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4366527-1&amp;h=3419626938&amp;u=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fnovavax%2F&amp;a=LinkedIn\" target=\"_blank\" rel=\"nofollow\">LinkedIn<\/a><\/u>\u00a0for more information.<\/p>\n<p>\n        <b>Contacts: <\/b>\n      <\/p>\n<p>\n        <u>Investors<br \/><\/u><br \/>\n        <span>Luis <\/span>Sanay<span>, <\/span>CFA<br \/>240-268-2022<br \/><a href=\"mailto:ir@novavax.com\" target=\"_blank\" rel=\"nofollow\">ir@novavax.com<\/a><\/p>\n<p>\n        <u>Media<br \/><\/u><br \/>\n        <span class=\"xn-person\">Giovanna Chandler<\/span><br \/>\n        <br \/>202-709-5563<br \/><a href=\"mailto:media@novavax.com\" target=\"_blank\" rel=\"nofollow\">media@novavax.com<\/a><\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder3423\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2343668\/Novavax_High_Res_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2343668\/Novavax_High_Res_Logo.jpg\" title=\"Novavax Logo (PRNewsfoto\/Novavax)\" alt=\"Novavax Logo (PRNewsfoto\/Novavax)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=PH23403&amp;sd=2025-02-20\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025-302381190.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025-302381190.html<\/a><\/p>\n<p>SOURCE  Novavax, Inc.<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=PH23403&amp;Transmission_Id=202502200800PR_NEWS_USPR_____PH23403&amp;DateId=20250220\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire GAITHERSBURG, Md. , Feb. 20, 2025 \/PRNewswire\/ &#8212; Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M\u2122 adjuvant, today announced it will report its fourth quarter and full year 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 27, 2025. Details of the event and replay are as follows: Conference call details: Date: February 27, 2025 Time: 8:30 a.m. U.S. ET URL to register phone: https:\/\/emportal.ink\/3PsP11e Dial-in number: (800) 836-8184 (Domestic) or (+1) (646) 357-8785 (International) Webcast: \u00a0 ir.novavax.com\/events Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back. Participants can &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815540","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire GAITHERSBURG, Md. , Feb. 20, 2025 \/PRNewswire\/ &#8212; Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M\u2122 adjuvant, today announced it will report its fourth quarter and full year 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 27, 2025. Details of the event and replay are as follows: Conference call details: Date: February 27, 2025 Time: 8:30 a.m. U.S. ET URL to register phone: https:\/\/emportal.ink\/3PsP11e Dial-in number: (800) 836-8184 (Domestic) or (+1) (646) 357-8785 (International) Webcast: \u00a0 ir.novavax.com\/events Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back. Participants can &hellip; Continue reading &quot;Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T13:09:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2343668\/Novavax_High_Res_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025\",\"datePublished\":\"2025-02-20T13:09:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/\"},\"wordCount\":354,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2343668\\\/Novavax_High_Res_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/\",\"name\":\"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2343668\\\/Novavax_High_Res_Logo.jpg\",\"datePublished\":\"2025-02-20T13:09:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2343668\\\/Novavax_High_Res_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2343668\\\/Novavax_High_Res_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/","og_locale":"en_US","og_type":"article","og_title":"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 - Market Newsdesk","og_description":"PR Newswire GAITHERSBURG, Md. , Feb. 20, 2025 \/PRNewswire\/ &#8212; Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M\u2122 adjuvant, today announced it will report its fourth quarter and full year 2024 financial results and operational highlights at 8:30 a.m. Eastern Time (ET) on Thursday, February 27, 2025. Details of the event and replay are as follows: Conference call details: Date: February 27, 2025 Time: 8:30 a.m. U.S. ET URL to register phone: https:\/\/emportal.ink\/3PsP11e Dial-in number: (800) 836-8184 (Domestic) or (+1) (646) 357-8785 (International) Webcast: \u00a0 ir.novavax.com\/events Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back. Participants can &hellip; Continue reading \"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T13:09:47+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2343668\/Novavax_High_Res_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025","datePublished":"2025-02-20T13:09:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/"},"wordCount":354,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2343668\/Novavax_High_Res_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/","name":"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2343668\/Novavax_High_Res_Logo.jpg","datePublished":"2025-02-20T13:09:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2343668\/Novavax_High_Res_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2343668\/Novavax_High_Res_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815540"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815540\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}